{
    "medicine_id": "e78ffc7a27549cb16e483ec194edbdf6f6c533ff",
    "platform_id": "DB05722",
    "metadata": {
        "name": "Stelara 5 mg Solution",
        "composition": "5 mg CGC 11047",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in lymphoma unspecified macular degeneration prostate cancer and solid tumors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "CGC 11047 is a polyamine analog with anti proliferative properties Polyamines are cell components considered essential for cell proliferation and differentiation They are believed to work by displacing polyamines from their natural binding sites and preventing cell replication CGC 11047 has been very well tolerated in Phase I clinical trials and has demonstrated promising activity in patients with advanced disease",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}